Clinical Features of Chinese Coronary Heart Disease Patients with Chronic Kidney Disease

REFERENCES

• Yusuf S, Reddy S, Ounpuu S, . Global burden of cardiovascular disease: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746–2753.
   PubMed Web of Science ®Google Scholar
• Marques MD, Santos RD, Parga JR, . Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis. 2010;209:481–486.
   PubMedGoogle Scholar
• Liu J, Hong Y, D’Agostino Sr. RB, . Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291:2591–2599.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, . Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847.
   PubMed Web of Science ®Google Scholar
• Han SS, Kim KW, Na KY, . Quality of life and mortality from a nephrologist’s view: A prospective observational study. BMC Nephrol. 2009;10:39.
   PubMedGoogle Scholar
• Eknoyan G, Lameire N, Barsoum R, . The burden of kidney disease: Improving global outcomes. Kidney Int. 2004;66:1310–1314.
   PubMed Web of Science ®Google Scholar
• Hou FF. Cardiovascular risk in Chinese patients with chronic kidney diseases: Where do we stand? Chin Med J (Engl). 2005;118:883–886.
   PubMedGoogle Scholar
• Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. 2005;94(Suppl.):S63–S67.
   Google Scholar
• Zhang L, Zuo L, Wang F, . Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol. 2006;17:2617–2621.
   PubMed Web of Science ®Google Scholar
• Holme I, Cater NB, Faergeman O, . Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End points Through Aggressive Lipid-lowering Trial (IDEAL). Ann Med. 2008;40:456–464.
   PubMed Web of Science ®Google Scholar
• Kiyosue A, Hirata Y, Ando J, . Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients. Circ J. 2010;74:786–791.
   PubMedGoogle Scholar
• Ma YC, Zuo L, Chen JH, . Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):S1–S266.
   PubMed Web of Science ®Google Scholar
• Brosius 3rd FC, Alpers CE, Bottinger EP, . Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2009;20:2503–2512.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, . A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Yang JG, Li J, Lu C, . Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease. J Atheroscler Thromb. 2010;17:395–401.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zuo L, Wang F, . Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc. 2007;82:822–827.
   PubMed Web of Science ®Google Scholar
• Cases Amenós A, González-Juanatey JR, Conthe Gutiérrez P, . Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol. 2010;63:225–228.
   PubMedGoogle Scholar
• Farmer JA, Torre-Amione G. Atherosclerosis and inflammation. Curr Atheroscler Rep. 2002;4:92–98.
   PubMedGoogle Scholar
• Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: Evidence and clinical application. Curr Atheroscler Rep. 2003;5:341–349.
   PubMedGoogle Scholar
• Soinio M, Marniemi J, Laakso M, . High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: A 7-year follow-up study. Diabetes Care. 2006;29:329–333.
   PubMed Web of Science ®Google Scholar
• Clearfield MB. C-reactive protein: A new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005;105: 409–416.
   PubMedGoogle Scholar
• Olivero JJ, Nguyen PT, Olivero JJ. Chronic kidney disease: A marker of cardiovascular disease. Methodist Debakey Cardiovasc J. 2009;5:24–29.
   PubMedGoogle Scholar
• Poulter N. Global risk of cardiovascular disease. Heart. 2003;89(Suppl. 2):ii2–ii5; discussion ii35–ii37.
   PubMedGoogle Scholar
• Wu Z, Yao C, Zhao D, . Sino-MONICA project: A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: Morbidity and mortality monitoring. Circulation. 2001;103:462–468.
   PubMed Web of Science ®Google Scholar